4SEPTEMBER - 2021TECH OUTLOOKCRISPR Technology: Exploring the Promise & Challenges of Genome EditingIN MY OPINIONBenjamin Borgo, Head of Portfolio Management for Genome Engineering and Modulation, MilliporeSigma08CXO INSIGHTSAnalytics as a Competitive Advantage Takes 3 Things­Access, Cleanliness, and ActionMatt Southwick, Executive Director, Clinical Systems and Analytical Reporting, Amgen [NASDAQ:AMGN]1812MATHEMATICAL APPROACH FOR PREDICTING RISKS EARLY-ON IN DRUG R&DApplied BioMathDr. Michelle M. Chen, VP and Head of Corporate Development, WuXi BiologicsRevamping Drug Discovery and Development through Technology Innovation16
< Page 3 | Page 5 >